Completed NA INTERVENTIONAL 2-arm NCT05371340

Quercetin's Effect on Bone Health and Inflammatory Markers

The Efficacy of Quercetin Supplementation on Bone Turnover Markers, Inflammatory Markers, Body Composition, and Physical Function in Post-Menopausal Women

Sponsor: Kennesaw State University

Conditions Osteoporosis, Postmenopausal

Interventions Placebo (500 mg) Quercetin (500 mg)

Updated 3 times since 2022 Last updated: May 7, 2022 Started: Aug 27, 2019 Primary completion: Apr 27, 2020 Completion: Apr 27, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05371340, this NA trial focuses on Osteoporosis, Postmenopausal and remains completed. Sponsored by Kennesaw State University, it has been updated 3 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kennesaw State University

Data source: Kennesaw State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kennesaw, United States